Showing results (801-810 of 5,813) with videos related to
Sort By:
Pageof 582
JMIR Aging|September 16, 2025
Dynamic Interactions Among Sleep Duration, Cognitive Function, and Depressive Symptoms in Middle-Aged and Older Chinese Adults: Temporal Network Analysis From CHARLSFurong Chen, Jiaying Li, Junchen Guo, et al.Journal of Alzheimer'S Disease Reports|September 15, 2025
Comorbidities and apolipoprotein E genotypes of patients with mild cognitive impairment in transition to Alzheimer's diseaseMingfei Li, Ying Wang, Lewis Kazis, et al.Pharmacological Research|September 14, 2025
Ion channels of the plasma membrane and endolysosomes: Roles in osmoregulation and volume regulation in immune cellsJingjing Huang, Hanhui Shi, Jiaying Shang, et al.BMC Pregnancy and Childbirth|September 26, 2025
Diagnosis and management of multiple-site heterotopic pregnancy with acute appendicitis: Case reportJiaying Shen, Yedi Huang, Rujing Fang, et al.Doklady. Biochemistry and Biophysics|August 24, 2021
Dioscorea deltoidea Leaf Extract (DDLE) Attenuates Cisplatin-Induced Ovarian Injury via Regulation of Oxidative StressJiaYing Wu, Ying Xiong, Bin Xu, et al.International Archives of Allergy and Immunology|July 20, 2025
Advances in Ferroptosis in Chronic Inflammatory Diseases of the Upper and Lower AirwaysJiaying Li, Jingyun Li, Yunbo Gao, et al.Frontiers in Public Health|December 18, 2025
Addressing the challenge of tuberculosis screening in diabetic populations: a narrative review of methods and strategiesYuqi Ma, Xiwei Lu, Xu Cao, et al.Frontiers in Psychology|December 11, 2025
Gross motor skills and social behavior in childhood: a public health perspective on their developmental associationJiaying Zhang, Yulan Zhou, Renke He, et al.International Journal for Equity in Health|January 25, 2025
Health economics assessment of statin therapy initiation thresholds for atherosclerosis prevention in China: a cost-effectiveness analysisTianyu Feng, Xiaolin Zhang, Jiaying Xu, et al.Journal of Cancer Research and Clinical Oncology|March 7, 2025
Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathwayCan Wang, Zhengzheng Wu, Jiaying Zhou, et al.Pageof 582